ClinicalTrials.gg
RecruitingNCT03059043Updated Aug 18, 2026

Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation

An interventional study of viscoelastic-free implantation system and standard viscoelastic-assisted Implantation system in Myopia, sponsored by Wenzhou Medical University. Recruiting at 5 sites in China. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Wenzhou Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2018; still recruiting 7 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study evaluates the safety and efficacy of a viscoelastic-free method for Implantable Collamer Lens(ICL) implantation to treat high myopia. The subjects undergo randomization of ICL implantation using the viscoelastic-free method on one eye and undergoing standard method on the other one. The post-operative data are collected for analysis.

Read the detailed description

Implantable Collamer Lens(ICL) implantation has been proved to be an effective refractive option for surgical correction of high myopia. Currently, standard method utilizing the viscoelastic agent to fill and maintain the anterior chamber during the implantation, this requires an additional step to remove the viscoelastic agent at the end of the surgery and may cause the intraocular pressure spike in the early post-operative phase due to the incomplete removal of the viscoelastics. The new method is viscoelastic-free, which can be achieved by using balanced salt solution irrigation during the implantation.

This study is a prospective, randomized, paired-eye study to compare the safety and efficacy of the viscoelastic-free method with the standard method. Subjects enrolled in the study will be randomized to receive viscoelastic-free method on one eye and undergo standard method on the other one.The clinical outcomes of two groups will be assessed at several follow-ups: 2 hours, 1 day, 1 week, 1 month, 3 months and 6 months post-operatively.

02

Conditions studied

  • Myopia

Browse trials for

Keywords

  • Phakic Intraocular Lenses
  • viscoelastic
03

In context

Myopia

1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.

This study's planned enrollment of 60 is below the median of 78 across 923 interventional studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Wenzhou Medical University is the lead sponsor of 94 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Documented stable refraction for at least 1 year(within 0.5D)
  • Best spectacle-corrected visual acuity (BCVA) of 20/40 or better
  • Clear central cornea
  • -0.5D to -18.0D of myopic refractive error
  • Normal anterior chamber depth at least 2.8 mm to endothelium
  • Endothelial cell density (ECD) more than 2000 cell/mm2
  • Pupil diameter smaller than 7.0 mm under mesopic condition
  • Discontinued 3 weeks for hard contact lens and 1 week for soft contact lens wear

Exclusion criteria

Exclusion Criteria:

  • Preexisting ocular diseases or conditions other than myopia, evidence of progressive or acute ocular disease
  • Evidence of connective tissue disease or other systemic diseases that may confound the results of the study;
  • Narrow angle of anterior chamber
  • Pregnant, lactating, or planning to become pregnant during the course of the trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    viscoelastic-free system

    Eyes in this group will use viscoelastic-free implantation system during the surgery

    Device: viscoelastic-free implantation system

  • Active comparator
    viscoelastic-assisted system

    Eyes in this group will utilize the standard viscoelastic-assisted Implantation system during the surgery

    Device: standard viscoelastic-assisted Implantation system

Interventions

  • Deviceviscoelastic-free implantation system

    Viscoelastic-free implantation system use balanced salt solution irrigation during the implantation

  • Devicestandard viscoelastic-assisted Implantation system

    This method utilize the viscoelastic agent to fill and maintain the anterior chamber during the implantation

06

What researchers measure

Primary outcomes

  1. Early Post-operative Intraocular Pressure

    Intraocular Pressure measured by non-contact tonometers

    Time frame: 2 hours after surgery

Secondary outcomes

  1. Corrected Visual Acuity (UCVA) at Distance

    Subjective refraction

    Time frame: baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery

  2. Uncorrected Visual Acuity (UCVA) at Distance

    Measure by visual acuity chart

    Time frame: baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery

  3. Endothelial Cell Density

    Measure by Specular Microscope

    Time frame: baseline, 1 month, 3 months and 6 months after surgery

  4. Vault measured by anterior segment OCT

    Vault measured by anterior segment OCT

    Time frame: 2 hours, 1 day, 1 week, 1 month, 3 months and 6 months after surgery

  5. Intraocular Pressure

    Intraocular Pressure measured by non-contact tonometers

    Time frame: baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery

  6. Refractive error (by Phoropter)

    subjective refraction by Phoropter

    Time frame: baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery

  7. Anterior chamber reaction (by a laser flare meter)

    anterior chamber flare value was examined by a laser flare meter

    Time frame: baseline, 2 hours, 1 day, 1 week after surgery

  8. Duration of operation

    Time from the first incision is made to the end of the surgery

    Time frame: at the time of the surgery

  9. Complications of ICL implantation

    Lens opacities, Cataract surgery, Pupillary block, Ocular hypertension or glaucoma

    Time frame: up to 6 months after surgery

07

Study locations

1 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2018 (actual). Primary completion is estimated for Jun 2028, 115 months after the start.

Of 200 non-industry interventional studies with no phase under Myopia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 115 months is above that.

Counting every sponsor, half of 434 studies reached it within 14 months; a quarter within 3 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2017
First posted
Feb 23, 2017
StartActual
Nov 16, 2018
Primary completionEst.
Jun 22, 2028
CompletionEst.
Jun 22, 2028
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03059043
Lead sponsor
Wenzhou Medical University
Responsible party
A-Yong Yu (Director of the Cataract Clinical Center, Wenzhou Medical University) — Principal investigator
First posted
Feb 23, 2017
Start date
Nov 16, 2018
Primary completion
Jun 22, 2028 (estimated)
Completion
Jun 22, 2028 (estimated)
Last update
Aug 18, 2026

Study contacts

AYong Yu, MD. PhD.
Contact
yaybetter@hotmail.com
+86-0577-88068880
Anpeng Pan, MD.OD.
Contact
pananpeng@126.com
AYong Yu, MD. PhD.
principal investigator · Wenzhou Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion